These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 7504978

  • 1. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA.
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.
    J Surg Oncol; 2006 Dec 01; 94(7):619-23. PubMed ID: 17111392
    [Abstract] [Full Text] [Related]

  • 11. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 01; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K, Culine S, Kramar A, Amato RJ, Bouzy J, Chen I, Droz JP, Logothetis CJ.
    J Clin Oncol; 2004 Oct 01; 22(19):3868-76. PubMed ID: 15302906
    [Abstract] [Full Text] [Related]

  • 14. Serum markers in germ cell neoplasms.
    Bartlett NL, Freiha FS, Torti FM.
    Hematol Oncol Clin North Am; 1991 Dec 01; 5(6):1245-60. PubMed ID: 1723408
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
    Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA.
    Br J Cancer; 1999 Jul 01; 80(9):1392-9. PubMed ID: 10424741
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC, McBride LC.
    Laryngoscope; 1999 Aug 01; 109(8):1241-4. PubMed ID: 10443827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Feasibility and relevance of tumor volumetry for stage classification and assessment of remission of germ cell tumors].
    Kreuser ED, Wellert M, Weidenmaier W, Egghart G, Hautmann R, Hetzel WD, Wolff H.
    Urologe A; 1989 Nov 01; 28(6):344-9. PubMed ID: 2557698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.